138 related articles for article (PubMed ID: 416305)
1. [Kupffer cells and dyslipoidoses].
Lageron A
Med Chir Dig; 1977; 6(7):453-7. PubMed ID: 416305
[No Abstract] [Full Text] [Related]
2. The lipidoses: morphologic changes in the nervous system in Gaucher's disease, GM2 gangliosidoses and Niemann-Pick disease.
Arey JB
Ann Clin Lab Sci; 1975; 5(6):475-88. PubMed ID: 812418
[TBL] [Abstract][Full Text] [Related]
3. The biochemistry of sphingolipid storage diseases.
Sandhoff K
Angew Chem Int Ed Engl; 1977 May; 16(5):273-85. PubMed ID: 406814
[No Abstract] [Full Text] [Related]
4. Disorders of lipid metabolism.
Brady RO
Biochem Soc Symp; 1972; (35):113-27. PubMed ID: 4217183
[No Abstract] [Full Text] [Related]
5. Genetic disorders of lysosomes.
Hirschhorn R; Weissmann G
Prog Med Genet; 1976; 1():49-101. PubMed ID: 180565
[No Abstract] [Full Text] [Related]
6. Biochemical approaches to the nosology of nervous system defects, II.
Brady RO
Birth Defects Orig Artic Ser; 1971 Feb; 7(1):33-6. PubMed ID: 4376033
[TBL] [Abstract][Full Text] [Related]
7. [Biochemical and pathological aspects of sphingolipidoses].
Landolt R
Bull Schweiz Akad Med Wiss; 1968 Jul; 24(1):73-94. PubMed ID: 5725178
[No Abstract] [Full Text] [Related]
8. Enzymatic abnormalities in diseases of sphingolipid metabolism.
Brady RO
Clin Chem; 1967 Jul; 13(7):565-77. PubMed ID: 5006481
[No Abstract] [Full Text] [Related]
9. The liver in lipid storage disease: biochemical basis of pathogenesis and clinical features.
Brady RO; James SP; Barranger JA
Prog Liver Dis; 1982; 7():331-46. PubMed ID: 6810410
[No Abstract] [Full Text] [Related]
10. Biochemical and metabolic basis of familial sphingolipidoses.
Brady RO
Semin Hematol; 1972 Jul; 9(3):273-84. PubMed ID: 4557342
[No Abstract] [Full Text] [Related]
11. [Lipidosis--metabolism].
Taketomi T
Tanpakushitsu Kakusan Koso; 1969 Mar; 14(4):346-56. PubMed ID: 4183081
[No Abstract] [Full Text] [Related]
12. [Disturbances of the lipid metabolism in relation to the nervous system. II. Sphingolipids and sphingolipidoses].
Tichý J
Cesk Neurol; 1973 Jan; 36(1):51-60. PubMed ID: 4685128
[No Abstract] [Full Text] [Related]
13. The chemistry and control of hereditary lipid diseases.
Brady RO
Chem Phys Lipids; 1974 Dec; 13(4):271-82. PubMed ID: 4217661
[No Abstract] [Full Text] [Related]
14. [Inherited storage disease associated mononuclear phagocytic system].
Takami T; Sasaki T; Tomatsu S; Sukegawa K; Orii T
Nihon Rinsho; 1989 Mar; 47(3):664-8. PubMed ID: 2499707
[No Abstract] [Full Text] [Related]
15. [Enzymatic aspects of sphingolipoidosis].
Kint JA; Dacremont G
Maandschr Kindergeneeskd; 1969 Sep; 37(3):74-85. PubMed ID: 5345122
[No Abstract] [Full Text] [Related]
16. [Sphingolipidosis in childhood].
Carnevale F
Pediatria (Napoli); 1968 Jun; 76(3):438-55. PubMed ID: 4905564
[No Abstract] [Full Text] [Related]
17. [Current data on cerebral lipidosis].
Escourolle R; Poirier J
Presse Med (1893); 1968 May; 76(23):1111-4. PubMed ID: 4173571
[No Abstract] [Full Text] [Related]
18. The role of lysosomes in the pathogeny of storage diseases.
Hers HG
Arch Belg Dermatol Syphiligr; 1972; 28(1):51-7. PubMed ID: 4266285
[No Abstract] [Full Text] [Related]
19. [Inborn errors of lipid metabolism, with special reference to sphingolipidosis].
Yabuuchi H; Sumi K
Saishin Igaku; 1969 Jun; 24(6):1165-75. PubMed ID: 4241018
[No Abstract] [Full Text] [Related]
20. Enzymological approaches to the lipidoses.
Brady RO
Ann Clin Lab Sci; 1977; 7(2):105-12. PubMed ID: 403847
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
